APR 22, 2022 4:15 PM PDT

Identifying "Cancer Culprits" in the Genome

WRITTEN BY: Carmen Leitch

Most cells carry the complete genome in their nucleus, and as cells divide and age, they can pick up mutations in their genome. Some mutations are harmless, and others can be repaired, but sometimes, harmful mutations stick around in the genome. If harmful mutations start to build up, or if they occur in certain critical genes, cancer can arise. The more scientists can learn about the mutations that drive cancer, the more likely it is that effective therapeutics can be created to stop cancer from developing or spreading. Scientists have now found more of those cancer-promoting mutations. The findings have been reported in Science.

Image credit: Pixabay

In this study, researchers used whole-genome sequencing to study cancers that occurred in over 12,000 patients, including primary tumors and metastatic cancers.

The study showed that some mutations can reveal a personalized history of how DNA has been damaged and repaired in one patient, and led to cancer. By sequencing the whole genome of cancerous cells, the researchers identified mutational signatures that could provide insights about the environmental and biological influences on cancer development, such as smoking, UV light exposure, or cellular disruptions. The researchers found 58 novel mutational signatures. They suggested that there may be other causes of cancer we don't know much about yet.

"The reason it is important to identify mutational signatures is because they are like fingerprints at a crime scene - they help to pinpoint cancer culprits. Some mutational signatures have clinical or treatment implications; they can highlight abnormalities that may be targeted with specific drugs or may indicate a potential Achilles heel in individual cancers," said Serena Nik-Zainal, a professor of genomic medicine and bioinformatics at the University of Cambridge.

The investigators also developed a computational tool that researchers and clinicians can use to assess new and old mutational signatures in patients, said Nik-Zainal. The tool is called FitMS, and it could improve the management of cancer cases.

"Mutational signatures are an example of using the full potential of WGS. We hope to use the mutational clues seen in this study and apply them back into our patient population, with the ultimate aim of improving diagnosis and management of cancer patients," added study co-author Professor Matt Brown, chief scientific officer of Genomics England.

Sources: University of Cambridge, Science

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JUN 19, 2022
Microbiology
Revealing the Origin & Spread of the Black Death
JUN 19, 2022
Revealing the Origin & Spread of the Black Death
Scientists have long sought to understand how Yersinia pestis, a gram-negative bacterium that causes plague, evolved int ...
JUL 04, 2022
Genetics & Genomics
Scientists Urge Study of Bacteria in Melting Glaciers
JUL 04, 2022
Scientists Urge Study of Bacteria in Melting Glaciers
Globally, temperatures are on the rise. Between the years of 2009 and 2019, glaciers around the world lost an average of ...
JUL 21, 2022
Clinical & Molecular DX
Best practices for lateral flow assay development
JUL 21, 2022
Best practices for lateral flow assay development
In our best practices blog, we explore how lateral flow assay design affects test performance. Read on to gain a deeper ...
JUL 31, 2022
Genetics & Genomics
A Brief History of Human Gene Editing
JUL 31, 2022
A Brief History of Human Gene Editing
DNA was characterized in 1953, and shortly after, the nature of the genetic code was revealed.
AUG 15, 2022
Cell & Molecular Biology
Researchers Create the First Synthetic Mouse Embryo
AUG 15, 2022
Researchers Create the First Synthetic Mouse Embryo
Scientists have been able to create stem cells that can mimic the early stages of mouse development. The researchers use ...
SEP 15, 2022
Clinical & Molecular DX
Critical Success Factors for Automating Laboratory Workflows
SEP 15, 2022
Critical Success Factors for Automating Laboratory Workflows
Staff shortages and increasing sample volume are the factors typically driving laboratories to assess their current work ...
Loading Comments...